Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
International
●ILROG: Field and dose guidelines for modern radiation therapy for extranodal lymphomas (2015)
Canada
●Choosing Wisely Canada: Don't request a fine-needle aspirate (FNA) for the evaluation of suspected lymphoma (updated 2020)
●CCO: Safety considerations for the implementation of subcutaneous rituximab formulation (2018)
●CCO: Consensus pathology recommendations for complex malignant hematology (2016)
●CCO: PET imaging in lymphoma (2015)
●CCO: Rituximab in lymphoma and chronic lymphocytic leukemia – A clinical practice guideline (2015)
United States
Europe
United Kingdom
●BSH: Guideline for the management of mantle cell lymphoma (2018)
Australia-New Zealand
Japan
●Japanese Society of Hematology (JSH): Practical guidelines for hematological malignancies, 2018 – Lymphoma: Mantle cell lymphoma (MCL) (published 2019)